- Home
- EJH vs RDHL Comparison
EJH vs RDHL Comparison
Compare EJH & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EJH | RDHL |
|---|---|---|
| Founded | 2018 | 2009 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.0M | 5.6M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | EJH | RDHL |
|---|---|---|
| Price | $0.74 | $1.01 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 120.0K | 71.5K |
| Earning Date | 12-29-2025 | 09-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $49,402,956.00 | $9,550,000.00 |
| Revenue This Year | N/A | $381.91 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 157.62 |
| 52 Week Low | $0.74 | $0.91 |
| 52 Week High | $64.00 | $6.80 |
Technical Indicators
Market Signals| Indicator | EJH | RDHL |
|---|---|---|
| Relative Strength Index (RSI) | 39.83 | 34.63 |
| Support Level | $0.81 | $1.10 |
| Resistance Level | $1.02 | $1.23 |
| Average True Range (ATR) | 0.08 | 0.06 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 11.44 | 38.76 |
Price Performance
Historical ComparisonAbout EJH E-Home Household Service Holdings Limited
E-Home Household Service Holdings Ltd is a household service company providing integrated household services through its website and WeChat platform across China. The company offers services including home appliance and housekeeping services. It operates its business mainly by receiving orders online and providing services offline. Its operations are organized into four reportable segments: appliance installation and maintenance services, housekeeping services, senior care services, and educational consulting services. The company generates the majority of its revenue from installation and maintenance.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.